supportive care mobile application for patients with nsclc

Conditions: Non Small Cell Lung Cancer; Quality of Life; Coping Skills

Summary: this research study is looking at the role of a supportive care mobile app in improving symptoms, coping skills, and quality of life in patients with non-small cell lung cancer.

this research study is a feasibility study, which is the first-time investigators are examining this supportive care mobile app intervention. the goal of this research study is to refine and examine the feasibility and benefits of a supportive care mobile app to improve symptoms, coping skills, and quality of life in patients with non-small cell lung cancer. many people diagnosed with lung cancer experience challenging symptoms and increased stress. to help address these concerns, this study is exploring how a mobile application (app) intervention, designed specifically for people with lung cancer, can expand the availability of much needed supportive care services. the research study procedures include: * a supportive care mobile app consisting of six intervention modules that focus on components of wellbeing, such as physical, social, functional, and emotional wellbeing * questionnaires asking about demographic information (e.g., gender, ethnicity, income) and participants' experience with cancer (e.g., quality of life, symptoms) * data collection from participants medical records after completing a baseline study questionnaire, participants will be randomized into two (2) study groups: * usual care group: participants will receive standard oncology care and attend their regular clinic visits. study staff will monitor participant use of supportive care services. * intervention group: participants will be provided with a study-issued tablet computer to access the mobile app and receive tutorial and instructions for how to use the app. participants will be in this research study for 12-14 weeks. it is expected that about 120 people will take part in this research study. the sponsors of this study are the national comprehensive cancer network (nccn) and astrazeneca pharmaceuticals. nccn is a non-profit alliance of leading cancer centers across the united states, and astrazeneca pharmaceuticals is a global bio-pharmaceutical company. these two sponsors are together providing funding and oversight for the conduct of this research study.

Eligibility criteria:
inclusion criteria: * age \>18 years * diagnosed with unresectable stage iii or iv nsclc in the past twelve weeks and receiving care with palliative intent (per clinician documentation in the electronic health record) * eastern cooperative oncology group performance status = 0-3 * plan to receive oncology care at one of the participating study sites * ability to read and respond to questions in english exclusion criteria: * significant uncontrolled psychiatric disorder (e.g., psychotic disorder, bipolar disorder, major depression) or other co-morbid disease (e.g., dementia, cognitive impairment), which the treating oncology clinician reports would prohibit the ability to participate in study procedures

Keywords: non small cell lung cancer portable electronic applications quality of life coping skills